2GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
3Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
4Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
2Vestbo J,Hurd SS, Agusti AG,et al. Global strategy for the diagnosis,management and prevention of chronic obstruc- tive pulmonary disease,GOLD executive summary [J]. Am J Respir Crit Care Med,2013,187(4) : 347-365.
3Aida Y,Shibata Y, Osaka D,et al. The relationship between serum uric acid and spirometic values in participants in a health check:the Takahata study [J]. Int J Med Sci,201 I, 8(6"), 470-478.
4Zhang X,Liu L,Liang R,et al. Hyperuricemia is a biomark- er of early mortality in patients with chronic obstructive pulmonary disease [J]. Int J Chron Obstruct Pulmon Dis, 2015,26(10) :2519-2523.
5Ozanturk E, Ucar ZZ, Varol Y, et al. Urinary uric acid ex- cretion as an indicator of severe hypoxia and mortality in patients with obstructive sleep apnea and chronic obstruc- tive pulmonary disease [J]. Rev Port Pneumo,2016,22 (1):18-26.
6Zhu Y,Pandya B J, Choi HK. Comorbidities of gour and hyperuricemia in ths US general population: NHANES 2007-2008 [J]. Am J Med,2012,125 : 679-687.
7Bartziokas K,Papaioannou AI, Loukides S,et al. Serum uric acid as a predictor of mortality and future exacerbations of COPD [J]. Eur Respir J,2014,43(1):43-53.
8Bardin T,Richette P. Definition of hyperuricemia and gouty conditions [J]. Curt Opin Rheumatol, 2014,26 (2) : 186-191.
9Billiet L, Doaty S, Katz JD, et al. Review of hyperuricemia as new marker for metabolic syndrome [J]. ISRN Rheuma-tol, 2014,2014: 852954.
10Wang L,Tang Y,Liu S,et al. Metabonomie profiling of serum and urine by (1)HNMR-based spectroscopy dis- criminates patients with chronic obstructive pulmonary disease and healthy individuals [J]. PLoS One,2013,8 (6) : e65675-e65682.
